Generic Semaglutide in Canada: Sandoz Approved, Not Yet Marketed
A third generic semaglutide has approval but no shelf presence. Here is where generic GLP-1 supply stands in Canada as of September 29.
Published · Editorial team
Where generic semaglutide stands
Two generic semaglutide products are on the Canadian market, from Apotex and Dr. Reddy's. Sandoz is the third: Health Canada issued its Notice of Compliance on September 16, 2026. As of September 29, both Sandoz DINs, 02571501 and 02571528, read Approved, not Marketed in the Drug Product Database.
What the status means
Approval says a product may be sold. "Marketed" says a manufacturer has started selling it. Only the second matters to a patient. Until it changes, the Sandoz product cannot be prescribed and dispensed from stock.
What this does not change
Generic semaglutide is a copy of one molecule. It does not cover tirzepatide (Mounjaro, Zepbound) or liraglutide (Saxenda), which remain brand-name only. A new semaglutide manufacturer does not alter the availability of those.
We will update this article when the database status changes.
Not a pharmacy
References and further reading
- Notice of Compliance, Sandoz semaglutide (NOC 38299) (Health Canada).
- Drug Product Database, DIN 02571501 (Health Canada).
- Drug Product Database, DIN 02571528 (Health Canada).
More from our Canadian network
We publish a small group of independent Canadian sites, each covering one part of this subject in more depth. These links leave this site.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.